Next |
home / stock / inmb / inmb message board
Subject | By | Source | When |
---|---|---|---|
Did the trial in ovarian ever start? | jondoeuk | investorshub | 04/11/2023 7:45:58 PM |
Don't need to convince us. We are fully | derkampfer | investorshub | 04/09/2023 1:10:54 PM |
Sure, it is early days in patients, but | jondoeuk | investorshub | 04/06/2023 11:10:04 PM |
blocked | dennisdave | investorshub | 12/01/2022 3:05:20 PM |
INMB chart....finally a reversal? | conix | investorshub | 03/30/2022 1:11:42 AM |
$INMB Chart | conix | investorshub | 09/21/2021 5:21:04 PM |
XPro news also impressive. Data very. The data | derkampfer | investorshub | 09/02/2021 12:10:24 PM |
INKmune news was impressive. Albeit one patient dosed | derkampfer | investorshub | 08/26/2021 3:45:08 PM |
Almost, $13 to $10 is a downward slope. | spartex | investorshub | 05/09/2021 12:03:21 AM |
Booooooom? More like, BurP! LOL. Still | spartex | investorshub | 05/08/2021 11:59:16 PM |
New run began today. Deeper dive Alzheimers drug | derkampfer | investorshub | 04/17/2021 2:27:32 AM |
$INMB just ran from $2.00 to 30.00 congrats | Fress | investorshub | 01/21/2021 12:56:46 PM |
I need a bigger rake to scoop up | john sezso | investorshub | 01/06/2021 9:58:37 PM |
Still crickets here.... | john sezso | investorshub | 01/06/2021 1:59:36 AM |
Good enough for Harry Reid it's good enough | john sezso | investorshub | 12/31/2020 2:46:09 PM |
They are speaking with Roth Capital right now | byrdiesoccer | investorshub | 10/28/2020 1:13:41 PM |
Shorts bring this to 8 I wanna buy | akamaii | investorshub | 10/17/2020 2:35:47 PM |
$INMB CHART >>>> going in position before test | l2 hunter | investorshub | 07/21/2020 3:48:27 PM |
Wow that public offering is peanuts ...Kaboom here tomorrow | starkd748 | investorshub | 07/20/2020 10:25:45 PM |
znewcar1: INMB 26% v1,8M c14.08 f10,9M H14.74 looking strong aft hours | znewcar1 | investorshangout | 07/20/2020 10:21:52 PM |
News, Short Squeeze, Breakout and More Instantly...
BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial resu...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...